Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, Bradycardia, Tachycardia, Ventricular Premature Complexes
Conditions
Keywords
Monitoring, Telemetry, Wearable device, Arrhythmia alarm, Signal loss, Satisfaction survey
Brief summary
This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring
Detailed description
This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring. After the data collection is completed, a satisfaction survey will be conducted with the medical staff. The data obtained simultaneously from HiCardi+ and MX40 will be analyzed, and the satisfaction survey responses from the medical staff will be reviewed to confirm the clinical convenience of the patch-type ECG monitoring device.
Interventions
DEVICEECG monitoring by telemetry device and patch-type ECG monitor at the same time
The patient undergoes electrocardiogram monitoring simultaneously through a telemetry device and a patch-type electrocardiograph.
Sponsors
Mezoo Co., Ltd.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Adults aged 19 years or older 2. Patients admitted to Chonnam National University Hospital who require ECG monitoring 3. Individuals who have expressed their intention to participate in this study or have obtained written consent from a proxy
Exclusion criteria
1. Individuals who are unable to provide consent themselves or through a legally designated representative 2. Individuals deemed unsuitable for participation in the clinical trial based on the researcher's judgment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The number of total QRS complex | Within 3 months after electrocardiogram monitoring procedure | Number of total QRS complex is compared based on the data obtained simultaneously from two devices. |
| The rate of signal loss | Within 3 months after electrocardiogram monitoring procedure | Rate of signal loss is compared based on the data obtained simultaneously from two devices. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Average heart rate | Within 3 months after electrocardiogram monitoring procedure | Average heart rate is compared based on the data obtained simultaneously from two devices. |
| The number of arrhythmia and technical alarm | Within 3 months after electrocardiogram monitoring procedure | Number of arrhythmia and technical alarm is compared based on the data obtained simultaneously from two devices. |
| Results of satisfaction survey | Within 3 months after electrocardiogram monitoring procedure | Satisfaction survey responses from the medical staff |
Contacts
Primary ContactSH Lee
Outcome results
None listed